Regarding the field of neurooncology, although some recent reports on establishing IDH1MUT high-grade cancer cell lines from corresponding mutated patient samples emerge [28], the establishment of IDH1 mutant in vitro models usually rely on genetic engineering of cells [29, 30]. The gene discussed is IDH1; the disease is cancer.